1. Samoylova A.G. Effektivnost kompleksnogo lecheniya bolnykh tuberkulezom legkikh s shirokoy lekarstvennoy ustoychivostyu vozbuditelya i prichiny ee formirovaniya. Diss. dokt. med. nauk. [Efficacy of comprehensive treatment of pulmonary tuberculosis patients with extensive drug resistance and causes of its development. Doct. Diss.]. Moscow, 2017.
2. Meyssonnier V., Bui T.V., Veziris N., Jarlier V., Robert J. Rifampicin mono-resistant tuberculosis in France: a 2005-2010 retrospective cohort analysis. BMC Infect Dis., 2014, no. 14 (18), pp. 1-7. doi: 10.1186/1471-2334-14-18.
3. The end TB strategy: global strategy and targets for tuberculosis prevention, care and control after 2015- Geneva: World Health Organization, 2014,
4. World Health Organization. Treatment guidelines for drug-resistant tuberculosis. Geneva, World Health Organization, 2016.
5. WHO treatment guidelines for isoniazid-resistant tuberculosis: Supplement to the WHO treatment guidelines for drug-resistant tuberculosis ‒ Geneva: World Health Organization, 2018.